Eli Lilly's 340B data policy draws new opposition from Missouri AG, Massachusetts hospitals
A controversial requirement for 340B hospitals to submit claims-level data to earn statutory drug discounts has earned a cease-and-desist letter from Missouri's attorney general and yet another lawsuit from disgruntled hospitals.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.